Prospects for improved bluetongue vaccines

Polly Roy1, Mark Boyce, Robert Noad

  • 1Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E7HT, UK. Polly.Roy@lshtm.ac.uk

Summary

Bluetongue virus (BTV) is a significant livestock pathogen. This review explores advanced vaccine technologies to improve protection against BTV, addressing limitations of current options.